News stories about Maximus (NYSE:MMS) have trended somewhat positive on Sunday, Accern Sentiment Analysis reports. The research firm identifies positive and negative media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Maximus earned a media sentiment score of 0.05 on Accern’s scale. Accern also assigned headlines about the health services provider an impact score of 45.8866553972658 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Here are some of the media stories that may have impacted Accern’s analysis:
Several brokerages recently commented on MMS. Zacks Investment Research raised Maximus from a “hold” rating to a “buy” rating and set a $73.00 price target for the company in a report on Wednesday, October 4th. Canaccord Genuity decreased their target price on Maximus from $62.00 to $61.00 and set a “hold” rating for the company in a research report on Friday. Robert W. Baird restated a “hold” rating and set a $64.00 target price on shares of Maximus in a research report on Friday, September 1st. BidaskClub lowered Maximus from a “hold” rating to a “sell” rating in a research report on Monday, July 24th. Finally, Maxim Group set a $66.00 target price on Maximus and gave the stock a “hold” rating in a research report on Thursday, August 3rd. One investment analyst has rated the stock with a sell rating and eight have given a hold rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $63.00.
Shares of Maximus (NYSE MMS) opened at $63.09 on Friday. Maximus has a 12 month low of $48.86 and a 12 month high of $66.96. The company has a market capitalization of $4,089.62, a P/E ratio of 20.29, a price-to-earnings-growth ratio of 1.92 and a beta of 1.32.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 30th. Stockholders of record on Wednesday, November 15th will be paid a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.29%. The ex-dividend date of this dividend is Tuesday, November 14th. Maximus’s dividend payout ratio is currently 5.66%.
In related news, General Counsel David Francis sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, August 18th. The stock was sold at an average price of $58.89, for a total transaction of $117,780.00. Following the transaction, the general counsel now directly owns 13,716 shares of the company’s stock, valued at approximately $807,735.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Richard A. Montoni sold 29,203 shares of the company’s stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $60.38, for a total value of $1,763,277.14. Following the completion of the transaction, the chief executive officer now directly owns 549,215 shares in the company, valued at $33,161,601.70. The disclosure for this sale can be found here. In the last quarter, insiders have sold 135,403 shares of company stock worth $8,387,641. Company insiders own 3.10% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Maximus (NYSE:MMS) Receiving Somewhat Positive Media Coverage, Report Shows” was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this story can be read at https://www.dispatchtribunal.com/2017/11/12/maximus-mms-getting-somewhat-positive-press-coverage-study-shows.html.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.